Are the Direct Oral Anticoagulants Better for Patients with Low Time in the Therapeutic Range on Vitamin K Antagonist Therapy?

被引:0
|
作者
Schaefer, Jordan K. [1 ]
Barnes, Geoffrey D. [2 ]
机构
[1] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI USA
[2] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI USA
关键词
WARFARIN; NONADHERENCE; MANAGEMENT; ADHERENCE;
D O I
10.1055/s-0044-1787299
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:791 / 794
页数:4
相关论文
共 50 条
  • [41] MT in anticoagulated patients: Direct oral anticoagulants versus vitamin K antagonists
    L'Allinec, Vincent
    Sibon, Igor
    Mazighi, Mikael
    Labreuche, Julien
    Kyheng, Maeva
    Boissier, Elodie
    Roy, Monica
    Gory, Benjamin
    Dargazanli, Cyril
    Desal, Hubert
    Lapergue, Bertrand
    Bourcier, Romain
    NEUROLOGY, 2020, 94 (08) : E842 - E850
  • [42] Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
    Susin Park
    Nam Kyung Je
    International Journal of Arrhythmia, 23 (1)
  • [43] Pros and Cons of Vitamin K Antagonists and Non-Vitamin K Antagonist Oral Anticoagulants
    Riva, Nicoletta
    Ageno, Walter
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (02): : 178 - 187
  • [44] Vitamin K Antagonist Treatment in Patients With Atrial Fibrillation and Time in Therapeutic Range in Four European Countries
    Cotte, Francois-Emery
    Benhaddi, Hicham
    Duprat-Lomon, Isabelle
    Doble, Adam
    Marchant, Nick
    Letierce, Alexia
    Huguet, Michael
    CLINICAL THERAPEUTICS, 2014, 36 (09) : 1160 - 1168
  • [45] DIRECT ORAL ANTICOAGULANTS THERAPY AFTER INTRACRANIAL HAEMORRHAGE WHILE ON VITAMIN K ANTAGONISTS
    Gomez, E.
    Garcia-Ramirez, P.
    Zabalza, A.
    Redondo, M.
    Quispe, I.
    Arregui, P.
    Montoya, M. C.
    Alvarellos, M.
    Millacoy, D. P.
    Paloma, M. J.
    HAEMATOLOGICA, 2016, 101 : 408 - 408
  • [46] Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes
    Rubboli, Andrea
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 : 22 - 28
  • [47] Meta-Analysis of Direct Oral Anticoagulants Compared With Vitamin K Antagonist for Left Ventricle Thrombus
    Mir, Tanveer
    Sattar, Yasar
    Bin Attique, Hassan
    Hussain, Tanveer
    Alraies, M. Chadi
    Sheikh, Mujeeb
    Qureshi, Waqas T.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 35 : 141 - 146
  • [48] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation
    Chen, Kuan-Hsuan
    Hsu, Yeh-Yun
    Chou, Chian-Ying
    Hsu, Chia-Chen
    Chang, Shih-Lin
    Yu, Wen-Chung
    Chang, Yuh-Lih
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (07) : 1268 - 1280
  • [49] Evaluation of the use of low-dose oral vitamin K in patients taking warfarin who have a low time in therapeutic range
    Luck, Krista K.
    Schreiber, Sally
    Duffey, Kristin E.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 35 (03) : 416 - 416
  • [50] Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation
    Okumura, Ken
    Hori, Masatsugu
    Tanahashi, Norio
    Camm, A. John
    CLINICAL CARDIOLOGY, 2017, 40 (02) : 126 - 131